SCHEMBL2904891

SCHEMBL2904891

Nc1nc(NCCCn2cc(C(=O)O)c(-c3ccc(Cl)cc3)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.42
GSK3A P49840 3/20 0.42
CDK1 P06493 2/20 0.40
CCNB2 O95067 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
EIF4E P06730 2/20 0.35
MAP4K4 O95819 1/20 0.34
MAPT P10636 5/20 0.34
NPC1 O15118 2/20 0.34
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
MITF O75030 1/20 0.33
LMNA P02545 1/20 0.33
NTSR1 P30989 1/20 0.33
KMT2A Q03164 1/20 0.33
PKM P14618 1/20 0.33
FOLH1 Q04609 1/20 0.33
SIRT5 Q9NXA8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2909714 0.91 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911792 0.91 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907084 0.91 GSK3B (0.37) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904425 0.90 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904612 0.90 GSK3B (0.36) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912610 0.89 MAPT (0.38) GSK3BGSK3AEIF4EMAPTALDH1A1
SCHEMBL2911406 0.89 EIF4E (0.37) GSK3BGSK3ACDK1EIF4EMAP4K4
SCHEMBL1219415 0.89 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2905948 0.89 EIF4E (0.37) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910908 0.88 GSK3B (0.41) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed